Verdonk, M. L., et al. “Improved protein–ligand docking using GOLD.” Proteins: Structure, Function, and Bioinformatics 52, no. 4 2003: 609–623. DOI: 10.1002/prot.10465.

Verdonk, M. L., et al. “Improved protein–ligand docking using GOLD.” Proteins: Structure, Function, and Bioinformatics 52, no. 4 2003: 609–623. DOI: 10.1002/prot.10465.

Watson P. Verdonk, M. , Hartshorn M.J. “A web-based platform for virtual screening.” Journal of Molecular Graphics and Modelling 22, no. 1 2003: 71–82. DOI: 10.1016/S1093-3263(03)00137-2.

Watson P. Verdonk, M. , Hartshorn M.J. “A web-based platform for virtual screening.” Journal of Molecular Graphics and Modelling 22, no. 1 2003: 71–82. DOI: 10.1016/S1093-3263(03)00137-2.

Williams, P.A., et al. “Crystal structure of human cytochrome P450 2C9 with bound warfarin.” Nature 424, no. 6947 2003: 464-468. DOI: 10.1038/nature01862.

Williams, P.A., et al. “Crystal structure of human cytochrome P450 2C9 with bound warfarin.” Nature 424, no. 6947 2003: 464-468. DOI: 10.1038/nature01862.

Yon J., Jhoti, H. “High-throughput structural genomics and proteomics: where are we now?.” Targets 2, no. 5 2003: 201–207. DOI: 10.1016/S1477-3627(03)02348-1.

Yon J., Jhoti, H. “High-throughput structural genomics and proteomics: where are we now?.” Targets 2, no. 5 2003: 201–207. DOI: 10.1016/S1477-3627(03)02348-1.

Blundell T.L., Jhoti, H. et al. “High-throughput crystallography for lead discovery in drug design.” Nature Reviews Drug Discovery 1 2002: 45-54. DOI: 10.1038/nrd706.

Blundell T.L., Jhoti, H. et al. “High-throughput crystallography for lead discovery in drug design.” Nature Reviews Drug Discovery 1 2002: 45-54. DOI: 10.1038/nrd706.

Carr R., Hann, M. “The right road to drug discovery?.” Modern Drug Discovery 5, no. 4 2002: 45-48.

Carr R., Hann, M. “The right road to drug discovery?.” Modern Drug Discovery 5, no. 4 2002: 45-48.

Carr R., Jhoti, H. “Structure-based screening of low-affinity compounds.” Drug Discovery Today 7, no. 9 2002: 522–527. DOI: 10.1016/S1359-6446(02)02245-6.

Carr R., Jhoti, H. “Structure-based screening of low-affinity compounds.” Drug Discovery Today 7, no. 9 2002: 522–527. DOI: 10.1016/S1359-6446(02)02245-6.

Murray C.W., Verdonk, M.L. “The consequences of translational and rotational entropy lost by small molecules on binding to proteins.” Journal of Computer-Aided Molecular Design 16, no. 10 2002: 741-753. DOI: 10.1023/A:1022446720849.

Murray C.W., Verdonk, M.L. “The consequences of translational and rotational entropy lost by small molecules on binding to proteins.” Journal of Computer-Aided Molecular Design 16, no. 10 2002: 741-753. DOI: 10.1023/A:1022446720849.

Jhoti H. “Structural genomics: lessons to be learnt.” Drug Discovery Today 6, no. 24 2001: 1261–1262. DOI: 10.1016/S1359-6446(01)02114-6.

Jhoti H. “Structural genomics: lessons to be learnt.” Drug Discovery Today 6, no. 24 2001: 1261–1262. DOI: 10.1016/S1359-6446(01)02114-6.

Jhoti, H. “High-throughput structural proteomics using x-rays.” Trends in Biotechnology 19, no. 10 2001: S67–S71. DOI: 10.1016/S0167-7799(01)01791-7.

Jhoti, H. “High-throughput structural proteomics using x-rays.” Trends in Biotechnology 19, no. 10 2001: S67–S71. DOI: 10.1016/S0167-7799(01)01791-7.